Is nuclear factor kappaB an attractive therapeutic target for treating cardiac hypertrophy?
暂无分享,去创建一个
[1] Richard T. Lee,et al. Identification of IEX-1 as a Biomechanically Controlled Nuclear Factor-&kgr;B Target Gene That Inhibits Cardiomyocyte Hypertrophy , 2002, Circulation research.
[2] Yasushi Matsumura,et al. Involvement of Nuclear Factor-&kgr;B and Apoptosis Signal-Regulating Kinase 1 in G-Protein–Coupled Receptor Agonist–Induced Cardiomyocyte Hypertrophy , 2002, Circulation.
[3] Michael Karin,et al. NF-κB at the crossroads of life and death , 2002, Nature Immunology.
[4] I. Rodger,et al. Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. , 1998, Circulation.
[5] Y. Kaneda,et al. A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkappaB binding site: evidence for a role of NFkappaB in ischemia-reperfusion injury. , 1997, Circulation.
[6] Keith W. Jones,et al. Cardiac-specific Abrogation of NF- κ B Activation in Mice by Transdominant Expression of a Mutant Iκ B α , 2001 .
[7] Y. Ahn,et al. A20 Is Dynamically Regulated in the Heart and Inhibits the Hypertrophic Response , 2003, Circulation.
[8] P. Boekstegers,et al. Retroinfusion of NFκB decoy oligonucleotide extends cardioprotection achieved by CD18 inhibition in a preclinical study of myocardial ischemia and retroinfusion in pigs , 2002, Gene Therapy.
[9] A. Krikos,et al. Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. , 1992, The Journal of biological chemistry.
[10] P. Anversa,et al. A matter of life and death: cardiac myocyte apoptosis and regeneration. , 2003, The Journal of clinical investigation.
[11] M. Hori,et al. Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy. , 2002, Journal of molecular and cellular cardiology.
[12] A. Matsumori,et al. The Role of Inflammatory Mediators in the Failing Heart: Immunomodulation of Cytokines in Experimental Models of Heart Failure , 2001, Heart Failure Reviews.
[13] R. Dietz,et al. Effect of NF- κ B Inhibition on TNF- α -induced Apoptosis and Downstream Pathways in Cardiomyocytes , 2001 .
[14] C. Croce,et al. TNF‐α signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF‐α receptor , 2002 .
[15] R. Beyaert,et al. A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. , 2000, Biochemical pharmacology.
[16] MasatsuguHori,et al. Involvement of Nuclear Factor-κB and Apoptosis Signal-Regulating Kinase 1 in G-Protein–Coupled Receptor Agonist–Induced Cardiomyocyte Hypertrophy , 2002 .
[17] J. Murabito,et al. Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study , 2002, Circulation.
[18] D. Levy,et al. The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.
[19] M. Wagner,et al. The Cytoprotective Effects of the Glycoprotein 130 Receptor-coupled Cytokine, Cardiotrophin-1, Require Activation of NF-κB* , 2001, Journal of Biological Chemistry.
[20] David Baltimore,et al. NF-κB: Ten Years After , 1996, Cell.
[21] A. Ma,et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. , 2000, Science.
[22] G. Dorn,et al. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. , 2001, Annual review of physiology.
[23] Michael Karin,et al. The Beginning of the End: IκB Kinase (IKK) and NF-κB Activation* , 1999, The Journal of Biological Chemistry.
[24] A. Lin,et al. Activation of nuclear factor- B is necessary for myotrophin-induced cardiac hypertrophy , 2002 .
[25] A. Lin,et al. Activation of NF-κB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes , 2001, Proceedings of the National Academy of Sciences of the United States of America.